{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T02:24:12Z","timestamp":1755224652335,"version":"3.43.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Italian Health Ministry","award":["RF-2019-12370456"],"award-info":[{"award-number":["RF-2019-12370456"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is an effective but potentially highly morbid treatment option for peritoneal surface malignancies. Adequate risk assessment is fundamental for clinical decision-making and informed patient consent. The aim of this study was to construct a validated nomogram predicting the risk of severe postoperative complications based exclusively on preoperative variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A prospective database of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single institution between February 1995 and April 2023 was reviewed. The cohort was divided randomly into derivation and validation cohorts (70 : 30). The primary outcome measure was postoperative complications (National Cancer Institute Common Terminology Criteria for Adverse Events grade \u2265 3). Binary logistic regression identified preoperative variables significantly associated with postoperative morbidity. A nomogram was constructed based on the results of the multivariable analysis. The model\u2019s performance was evaluated on the validation cohort by receiver operating characteristic curve analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 1039 patients were analysed. The majority of the patients were female (58.8%) and the median age was 56 (interquartile range 46\u201364) years. The postoperative complication rate was 37.7%, and the reoperation rate 12.7%. A nomogram was constructed based on the following predictive factors: age, body mass index, high-grade histology, disease identified in the left upper quadrant and surrounding the stomach and small bowel mesentery on preoperative imaging, preoperative white blood cell count, and Onodera nutritional index score. Receiver operating characteristic curve analysis showed an area under the curve of 0.707 with accurate calibration curves.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Preoperative variables were selected and included in a simple nomogram predicting the risk of postoperative complications. This nomogram could aid clinicians in decision-making and patients in making informed decisions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjsopen\/zraf064","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T20:54:00Z","timestamp":1755032040000},"source":"Crossref","is-referenced-by-count":0,"title":["Predicting postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: retrospective cohort study"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-910X","authenticated-orcid":false,"given":"Lorena","family":"Martin-Roman","sequence":"first","affiliation":[{"name":"Department of Surgery, Colorectal and Peritoneal Oncology Centre, Christie Foundation Trust , Manchester ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"Kusamura","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Guaglio","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-836X","authenticated-orcid":false,"given":"Gaia","family":"Colletti","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Cavalleri","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-2642","authenticated-orcid":false,"given":"Dario","family":"Baratti","sequence":"additional","affiliation":[{"name":"Peritoneal Malignancy Program, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori , Milan ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"2025081216535036100_zraf064-B1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"2025081216535036100_zraf064-B2","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J Clin Oncol"},{"key":"2025081216535036100_zraf064-B3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0b013e3181a45d86","article-title":"Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality","volume":"249","author":"Chua","year":"2009","journal-title":"Ann Surg"},{"key":"2025081216535036100_zraf064-B4","doi-asserted-by":"crossref","first-page":"e186847","DOI":"10.1001\/jamanetworkopen.2018.6847","article-title":"Morbidity and mortality rates following cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy compared with other high-risk surgical oncology procedures","volume":"2","author":"Foster","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025081216535036100_zraf064-B5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jso.23231","article-title":"Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres","volume":"107","author":"Kusamura","year":"2013","journal-title":"J Surg Oncol"},{"key":"2025081216535036100_zraf064-B6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12094-018-1944-y","article-title":"Goal-directed therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a prospective observational study","volume":"21","author":"Esteve-P\u00e9rez","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"2025081216535036100_zraf064-B7","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.3390\/cancers14235824","article-title":"Complications and mortality rate of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Italian Peritoneal Surface Malignancies Oncoteam results analysis","volume":"14","author":"Carboni","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025081216535036100_zraf064-B8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/DCR.0000000000000149","article-title":"Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients","volume":"57","author":"Baratti","year":"2014","journal-title":"Dis Colon Rectum"},{"key":"2025081216535036100_zraf064-B9","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"2025081216535036100_zraf064-B10","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1245\/s10434-020-08379-9","article-title":"Systematic review of factors affecting quality of life after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Leimk\u00fchler","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B11","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1245\/s10434-015-5012-3","article-title":"A novel tool for predicting major complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"23","author":"Baumgartner","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B12","doi-asserted-by":"crossref","first-page":"e2212930","DOI":"10.1001\/jamanetworkopen.2022.12930","article-title":"Development and validation of an explainable machine learning model for major complications after cytoreductive surgery","volume":"5","author":"Deng","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025081216535036100_zraf064-B13","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1245\/s10434-023-13657-3","article-title":"Predicting severe complications from cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a data-driven, machine learning approach to augment clinical judgment","volume":"30","author":"Adam","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2025081216535036100_zraf064-B15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","article-title":"Prior surgical score: an analysis of the prognostic significance of an initial nondefinitive surgical intervention in patients with peritoneal carcinomatosis of a colorectal origin undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy","volume":"61","author":"Paul","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"2025081216535036100_zraf064-B16","first-page":"1001","article-title":"Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"2025081216535036100_zraf064-B17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"2025081216535036100_zraf064-B18"},{"key":"2025081216535036100_zraf064-B19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"2025081216535036100_zraf064-B20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/jso.21388","article-title":"Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies","volume":"100","author":"Deraco","year":"2009","journal-title":"J Surg Oncol"},{"key":"2025081216535036100_zraf064-B21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","article-title":"Peritonectomy procedures","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"2025081216535036100_zraf064-B22","doi-asserted-by":"crossref","first-page":"e1460","DOI":"10.1002\/wics.1460","article-title":"The Akaike information criterion: background, derivation, properties, application, interpretation, and refinements","volume":"11","author":"Cavanaugh","year":"2019","journal-title":"WIREs Comput Stat"},{"key":"2025081216535036100_zraf064-B23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2288-13-33","article-title":"External validation of a Cox prognostic model: principles and methods","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"2025081216535036100_zraf064-B24","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.ejso.2020.08.006","article-title":"Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) Society recommendations\u2014part II: postoperative management and special considerations","volume":"46","author":"H\u00fcbner","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2025081216535036100_zraf064-B25","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","article-title":"Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations\u2014part I: preoperative and intraoperative management","volume":"46","author":"H\u00fcbner","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2025081216535036100_zraf064-B26","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1245\/s10434-014-4297-y","article-title":"Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis","volume":"22","author":"Simkens","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/bja\/54.8.811","article-title":"Epidemiology in anaesthesia. II: factors affecting mortality in hospital","volume":"54","author":"Farrow","year":"1982","journal-title":"Br J Anaesth"},{"key":"2025081216535036100_zraf064-B28","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/bjs.5058","article-title":"Comparison of surgical risk score, POSSUM and p-POSSUM in higher-risk surgical patients","volume":"92","author":"Brooks","year":"2005","journal-title":"Br J Surg"},{"key":"2025081216535036100_zraf064-B29","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1245\/s10434-020-08237-8","article-title":"Surgeons\u2019 ability to predict the extent of surgery prior to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Hentzen","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B30","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1245\/s10434-013-3049-8","article-title":"Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS + HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status","volume":"20","author":"Ihemelandu","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B31","first-page":"5330","article-title":"Survival and complications of cytoreductive surgery and hyperthermic intraperitonealchemotherapy in elderly patients: a systematic review and metaanalysis","volume":"25","author":"Tao","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025081216535036100_zraf064-B32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.amjsurg.2008.06.037","article-title":"Preoperative performance status predicts outcome following heated intraperitoneal chemotherapy","volume":"196","author":"Reuter","year":"2008","journal-title":"Am J Surg"},{"key":"2025081216535036100_zraf064-B33","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1245\/s10434-015-4892-6","article-title":"Predictors of severe morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis","volume":"23","author":"Simkens","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B34","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1245\/s10434-007-9406-8","article-title":"Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy\u2014a journey to becoming a nationally funded peritonectomy center","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/SLA.0b013e31825704e3","article-title":"Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"256","author":"Baratti","year":"2012","journal-title":"Ann Surg"},{"key":"2025081216535036100_zraf064-B36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s12094-019-02195-8","article-title":"Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy","volume":"22","author":"Cascales Campos","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"2025081216535036100_zraf064-B37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1245\/s10434-019-07797-8","article-title":"Diaphragmatic peritoneal stripping versus full-thickness resection in CRS\/HIPEC: is there a difference?","volume":"27","author":"Sullivan","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.suronc.2015.11.003","article-title":"Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: risk factors for ICU admission and morbidity prognostic score","volume":"25","author":"Malfroy","year":"2016","journal-title":"Surg Oncol"},{"key":"2025081216535036100_zraf064-B39","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1007\/s10350-005-0045-5","article-title":"Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study","volume":"48","author":"Loungnarath","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"2025081216535036100_zraf064-B40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ejso.2015.04.005","article-title":"The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"41","author":"Kusamura","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"2025081216535036100_zraf064-B41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/bjs.7305","article-title":"Nutritional predictors of postoperative outcome in pancreatic cancer","volume":"98","author":"Kanda","year":"2011","journal-title":"Br J Surg"},{"key":"2025081216535036100_zraf064-B42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ciresp.2018.08.015","article-title":"Prognostic Nutritional Index predicts morbidity after curative surgery for colorectal cancer","volume":"97","author":"Bail\u00f3n-Cuadrado","year":"2019","journal-title":"Cir Esp (Engl Ed)"},{"key":"2025081216535036100_zraf064-B43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/01635581.2017.1339093","article-title":"Prognosis prediction for postoperative esophageal cancer patients using Onodera\u2019s prognostic nutritional index","volume":"69","author":"Matsumoto","year":"2017","journal-title":"Nutr Cancer"},{"key":"2025081216535036100_zraf064-B44","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1245\/s10434-018-6823-9","article-title":"Postoperative complications independently predict cancer-related survival in peritoneal malignancies","volume":"25","author":"Choudry","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2025081216535036100_zraf064-B45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/02656736.2017.1367846","article-title":"Ninety-day post-operative morbidity and mortality using the National Cancer Institute\u2019s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"34","author":"Alyami","year":"2018","journal-title":"Int J Hyperth"}],"container-title":["BJS Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/9\/4\/zraf064\/63985820\/zraf064.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjsopen\/article-pdf\/9\/4\/zraf064\/63985820\/zraf064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T20:54:07Z","timestamp":1755032047000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjsopen\/article\/doi\/10.1093\/bjsopen\/zraf064\/8227433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjsopen\/zraf064","relation":{},"ISSN":["2474-9842"],"issn-type":[{"type":"electronic","value":"2474-9842"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,1]]},"article-number":"zraf064"}}